Cargando…
IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology
BACKGROUND: Intravenous immunoglobulin (IVIg) is currently in clinical study for Alzheimer’s disease (AD). However, preclinical investigations are required to better understand AD-relevant outcomes of IVIg treatment and develop replacement therapies in case of unsustainable supply. METHODS: We inves...
Autores principales: | St-Amour, Isabelle, Paré, Isabelle, Tremblay, Cyntia, Coulombe, Katherine, Bazin, Renée, Calon, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997966/ https://www.ncbi.nlm.nih.gov/pubmed/24655894 http://dx.doi.org/10.1186/1742-2094-11-54 |
Ejemplares similares
-
DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice
por: Arsenault, Dany, et al.
Publicado: (2011) -
Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice
por: Arsenault, Dany, et al.
Publicado: (2020) -
Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model
por: Landry, Olivier, et al.
Publicado: (2023) -
Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
por: Mitrano, Darlene A., et al.
Publicado: (2021) -
Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2019)